Find policies, billing codes, payers, states, and providers
Gender Dysphoria Treatment
Customize your policy alerts
Sign up for Colorado Rocky Mountain Health Plans Policy 2026T0580U alerts
Get alerted when Policy 2026T0580U changes without checking for updates manually.
Monitor payer policy activity
Medical policy governing coverage and medical necessity criteria for surgical and related treatments for Gender Dysphoria for UnitedHealthcare Commercial and Individual Exchange benefit plans (with listed state and plan exceptions). Affects providers requesting authorization for gender-affirming surgeries and ancillary services.
Added instruction for fully insured group policies in Washington D.C. to refer to the Benefit Considerations section for additional information.
Clarified that for fully-insured group policies in New York, medically necessary treatment is based on WPATH Standards of Care version 8.
Archived previous policy version 2026T0580T.
Coverage Criteria and Scope
Medical necessity criteria for surgical treatment
Covered when ALL of the following are met:
Covered services (when the member's plan allows)
Coverage is plan- and law-dependent; when a plan covers gender dysphoria treatment, included services are:
Subject to the member-specific benefit plan document and applicable laws; certain plans may not cover all listed surgical treatments.
Jurisdiction-specific coverage adaptations
For fully-insured group policies in specified jurisdictions, alternative requirements apply:
Applies to fully-insured group policies in Washington, D.C. only.
Applies to fully-insured group policies in New York only, including the NY Essential Plan.
This Medical Policy does not apply to individuals with ambiguous genitalia or disorders of sexual development. This exclusion is stated in the Coverage Rationale and should be applied when determining whether the policy’s surgical criteria and prior authorization requirements are relevant for a given member.
Certain ancillary procedures performed in conjunction with gender-affirming surgery are considered cosmetic and not medically necessary. Examples listed in the policy include: abdominoplasty, blepharoplasty, body contouring (fat transfer, lipoplasty, panniculectomy), brow lift, calf implants, facial implants (cheek, chin, nose), injection of fillers or neurotoxins, face/forehead lift or neck tightening, facial bone remodeling, laser or electrolysis hair removal not related to genital reconstruction, hair transplantation, lip augmentation/reduction, liposuction, mastopexy, pectoral implants, rhinoplasty, rib reconstruction, and skin resurfacing (dermabrasion, chemical peels, laser).
Coverage is governed by the member specific benefit plan document and applicable laws. The policy specifically excludes treatments and procedures that are explicitly excluded by the member’s benefit plan, as well as services provided outside the United States. Plans may vary in which services they cover; refer to the member specific benefit plan for final determinations.
Most clinical guidelines do not recommend medical interventions for pre-pubertal children. For adolescents, guidance is mixed and evidence is limited: several guidelines recommend against some adolescent surgeries, some support only chest (mastectomy) procedures, and many emphasize the need for careful multidisciplinary assessment. Documentation for adolescents should address persistence of gender dysphoria, decision-making capacity, management of mental health conditions, Tanner stage where relevant, and fertility counseling prior to interventions.
The member specific benefit plan document governs coverage and may differ from this Medical Policy. When there is a conflict between this policy and the member’s plan document or applicable federal/state mandates, the member specific benefit plan controls. Before applying this policy, verify the member’s plan terms and any required prior authorization processes.
An expanded list of ancillary procedures considered cosmetic and generally not medically necessary when performed as part of gender-affirming surgery is provided for operational clarity. These procedures include, but are not limited to: abdominoplasty, blepharoplasty, body contouring (fat transfer, lipoplasty, panniculectomy), brow lift, calf implants, cheek/chin/nose implants, clavicular shortening, injectable fillers or neurotoxins, face/forehead lift and neck tightening, facial bone remodeling, laser/electrolysis hair removal not related to genital reconstruction, hair transplantation, lip augmentation or reduction, liposuction, mastopexy, pectoral implants, rhinoplasty, rib reconstruction, and skin resurfacing (dermabrasion, chemical peels, laser). Refer to the Benefit Considerations for member-plan variability.
Services that do not meet the policy’s Coverage Rationale indications or that are designated cosmetic by the member-specific benefit plan may be denied as not medically necessary. Examples include the ancillary cosmetic procedures listed in the policy and any services explicitly excluded by the member’s plan.
Current evidence for the efficacy and safety of genital gender-affirming surgeries (including vaginoplasty and other genital GAS) in adolescents is unclear or lacking. The policy cites limited, low-quality studies and guideline-based uncertainty, and therefore these procedures lack sufficient supportive evidence in the adolescent population.
Applicable Codes and Coding Guidance
| 11950 | Subcutaneous injection of filling material (e.g., collagen); 1 cc or less. |
| 11951 | Subcutaneous injection of filling material (e.g., collagen); 1.1 to 5.0 cc. |
| 11952 | Subcutaneous injection of filling material (e.g., collagen); 5.1 to 10.0 cc. |
| 11954 | Subcutaneous injection of filling material (e.g., collagen); over 10.0 cc. |
| 14000 | Adjacent tissue transfer or rearrangement, trunk; defect 10 sq cm or less. |
| 15771 | Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate |
| 15772 | each additional 50 cc injectate |
| 15774 | Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; 25 cc or less injectate |
| 17380 | Electrolysis epilation, each 30 minutes |
| 53410 | Urethroplasty, 1-stage reconstruction of male anterior urethra. |
| 54125 | Amputation of penis; complete. |
| 54400 | Insertion of penile prosthesis; non-inflatable (semi-rigid). |
| 54520 | Orchiectomy, simple (including subcapsular), with or without testicular prosthesis, scrotal or inguinal approach. |
| 56625 | Vulvectomy simple; complete. |
| 54405 | Insertion of multi-component, inflatable penile prosthesis, including placement of pump, cylinders, and reservoir. |
| 54406 | Removal of all components of a multi-component, inflatable penile prosthesis without replacement of prosthesis. |
| 54408 | Repair of component(s) of a multi-component, inflatable penile prosthesis / Removal and replacement of all component(s) of a multi-component, inflatable penile prosthesis. |
| 54410 | Removal and replacement of all component(s) of a multi-component inflatable penile prosthesis at the same operative session. |
| 54411 | Removal and replacement of all components of a multi-component inflatable penile prosthesis through an infected field at the same operative session, including irrigation and debridement of infected tissue. |
| 54415 | Removal of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis, without replacement of prosthesis. |
| 54416 | Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis at the same operative session. |
| 54417 | Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis through an infected field at the same operative session, including irrigation and debridement of infected tissue. |
| 54520 | Orchiectomy, simple (including subcapsular), with or without testicular prosthesis, scrotal or inguinal approach. |
| 54660 | Insertion of testicular prosthesis (separate procedure). |
| F64.0 | Transsexualism. |
| F64.1 | Dual role transvestism. |
| F64.2 | Gender identity disorder of childhood. |
| F64.8 | Other gender identity disorders. |
| F64.9 | Gender identity disorder, unspecified. |
| Z87.890 | Personal history of sex reassignment. |
Prior Authorization, Documentation, and Provider Expectations
Preauthorization requires meeting medical necessity criteria
Surgical treatments require documentation that the individual meets all listed medical necessity criteria (persistent, well-documented gender dysphoria; capacity to consent; age ≥18; favorable psychosocial-behavioral evaluation) and any procedure‑specific requirements (e.g., hormone therapy, real‑life experience) prior to prior authorization and coverage determination.
Prior authorization required for listed procedure codes
Prior authorization is indicated for the surgical procedure codes listed in the policy's Applicable Codes section; submit authorization requests that reference the applicable CPT/Procedure codes included in the policy.
Prior authorization expectations for adolescent GAS
For adolescents, prior authorization requests are expected to include documentation of multidisciplinary assessment, clear indication and consent, fertility counseling, and counseling/management of mental health conditions; adolescent surgical procedures are uncommon and require thorough documentation.
Confirm member plan and prior authorization requirements
Verify the member specific benefit plan and any applicable federal or state mandates before requesting authorization; the member specific benefit plan document governs coverage and may impose different prior authorization requirements.
Therapy prerequisites
For certain procedures (e.g., breast augmentation, genital surgeries, voice masculinization), prior authorization requires documentation that the required durations of continuous hormone therapy and/or real‑life experience have been completed as specified in the policy.
Voice therapy and hormone therapy sequencing
Document completion of recommended voice therapy and the timing of hormone therapy relative to voice procedures; the policy recommends voice therapy prior to or combined with surgical voice procedures and hormone therapy prior to further voice intervention.
Voice therapy before surgery
Voice therapy is often expected before phonosurgery for feminizing voice outcomes; include documentation of presurgical voice lessons and/or therapy in authorization requests for voice modification surgery.
Guideline sequencing for genital surgery
When requesting genital surgery authorization, include documentation that the Endocrine Society–recommended sequencing has been followed: delay genital surgery until age of majority and document completion of at least one year of consistent hormone therapy unless contraindicated.
Required clinical documentation
Provide clinical documentation demonstrating persistent, well‑documented gender dysphoria; capacity to give informed consent; age ≥18 (unless jurisdictional adaptations apply); favorable psychosocial evaluation; and any procedure‑specific assessments from Qualified Healthcare Professionals.
Diagnosis and benefits documentation
Establish and document the diagnosis of gender incongruence/gender dysphoria in the medical record and confirm member benefits by referencing the member specific benefit plan when submitting authorization requests.
Adolescent assessment documentation
For adolescents, include documentation supporting presence and persistence of gender dysphoria/incongruence, decision‑making capacity, management of mental health conditions, Tanner stage where relevant for puberty suppression, and fertility counseling prior to interventions.
Clinician and MHP agreement; hormone therapy documentation
Include written assessments showing agreement between the mental health practitioner and the endocrine/medical clinician that surgery is medically necessary, and document completion of recommended hormone therapy when required by the policy.
Documentation may trigger denial
Lack of required medical records or failure to demonstrate that the clinical criteria are met may result in denial; medical records documentation may be required to assess whether the member meets clinical criteria but does not guarantee coverage.
Non-indicated services may be denied
Services that do not meet the indications listed in the Coverage Rationale section or are designated cosmetic per the member specific benefit plan may be denied as not meeting coverage criteria.
Plan exclusions and cosmetic/foreign treatment denials
Services specifically excluded by the member specific benefit plan, procedures considered cosmetic, or treatments received outside the United States may be denied; check plan exclusions when submitting authorization requests.
Evidence insufficiency as denial risk
Sparse, low‑quality, or absent evidence for many procedures (including voice interventions and many adolescent surgeries) may prompt medical necessity review and potential denial when evidence is insufficient.
Member plan governs
Coverage decisions must be made in reference to the member specific benefit plan document and applicable federal or state mandates; in the event of conflict, the member specific benefit plan governs coverage.
Key Definitions
Gender Dysphoria is defined consistent with DSM-5-TR criteria as a marked incongruence between experienced/expressed gender and assigned gender for at least 6 months, manifested by specified indicators (for example, a strong desire to be rid of primary/secondary sex characteristics) and accompanied by clinically significant distress or impairment. This definition underpins eligibility assessments in the Coverage Rationale.
Clinical Evidence and Background
Systematic reviews and evidence summaries cited in the policy report variable outcomes by procedure. For genital reconstruction, a systematic review of phalloplasty reported a very high overall complication rate (noted in the policy’s evidence summaries), while transfemale vaginoplasty meta-analyses report high patient-reported satisfaction (for example, near 91% satisfaction in one pooled series) but also notable neovaginal complication rates (around 32.5% in another review). Voice and facial procedures have sparse, low-quality evidence with small studies and mixed outcomes. These findings support the policy’s requirement for specialist assessments, multidisciplinary care, and cautious application of invasive procedures, particularly in adolescents.
Policy Changes and Versioning
Added state-specific guidance: for fully‑insured Washington D.C. group plans, coverage is based on the most recent WPATH Standards of Care and must not conflict with DISB Bulletin; for fully‑insured New York plans (including NY Essential Plan), coverage is based on WPATH Standards of Care version 8.
Archived prior policy version 2026T0580T.
Material changes in this policy include added operational instructions for fully-insured group policies in specific jurisdictions. The policy now explicitly references District of Columbia DISB guidance and aligns coverage for DC fully-insured plans with the most recent WPATH Standards of Care to the extent not conflicting with DISB requirements. It also clarifies that for fully-insured New York plans (including the NY Essential Plan) coverage for medically necessary treatment is based on WPATH Standards of Care version 8. A prior policy version was archived as part of this update.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.